January 2021 - Invex Therapeutics Ltd

Small Caps – Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

COVID-19 Impact on IIH – J Neurol article by Prof Alex Sinclair

Partners

Contact Us

Address

Level 1, 38 Rowland St
Subiaco Perth WA 6008

Phone

+61 (08) 6382 0137

ACN

632145334

Email

info@invextherapeutics.com

Subscribe to our updates

Copyright © 2022 Invex Therapeutics. All rights reserved. Disclaimer.

Created by Anomaly.